Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Hey Mercedesman, how about an update to this please?

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Feb 07, 2023 2:43pm

120 Views

Post# 35272522

RE:RE:Hey Mercedesman, how about an update to this please?

January 24, 2021

mercedesman wrote: No need to update

My post still stands up well, to this day, if I do say so myself.

IMO we only need two things :

1. a stance from Mgt. that Covid is not a net negative (delays to Tigris, and PMX "ineffective" against CV-19) but rather a net positive (alleviate CRRT equipment shortage, Home Dialysis much more important/urgent now, Japanese and European studies that show PMX can positively impact a subset of patients, by reducing cytokine storm in up to 1/3 of hosptilaized patients)

2. a US presence wherein valuations (and multipiers) as discussed are actually possible...as shown by other US listed Companies (many or most with perhaps much less to offer)

MM